- Israeli Pharmaceutical Industry: Teva and Generic Drugs
Azilect: Technion Research and Clinical Development
Technion researchers John Finberg and Moussa Youdim developed rasagiline with Teva, later marketed as Azilect. In the 2009 ADAGIO trial, the primary delayed-start criteria were met at 1 mg daily but not at 2 mg.